A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Oncolytic Virus Therapy in Metastatic Triple Negative Breast Cancer

Kai Sun; Yitian Xu; Sunil  Mathur; Eric H. Bernicker; Jenny C. Chang

doi:10.1158/1078-0432.CCR-22-0622

A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Oncolytic Virus Therapy in Metastatic Triple Negative Breast Cancer

Kai Sun, Yitian Xu, Sunil Mathur, Eric H. Bernicker, Jenny C. Chang

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Number of pages	25
Journal	Clinical Cancer Research
DOIs	https://doi.org/10.1158/1078-0432.CCR-22-0622
State	Published - Oct 15 2022

Divisions

Medical Oncology

Access to Document

10.1158/1078-0432.CCR-22-0622

Cite this

@article{dec8413235d7416aa1777995d3baebad,

title = "A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Oncolytic Virus Therapy in Metastatic Triple Negative Breast Cancer",

author = "Kai Sun and Yitian Xu and Sunil Mathur and Bernicker, \{Eric H.\} and Chang, \{Jenny C.\}",

year = "2022",

month = oct,

day = "15",

doi = "10.1158/1078-0432.CCR-22-0622",

language = "English (US)",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

}

TY - JOUR

T1 - A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Oncolytic Virus Therapy in Metastatic Triple Negative Breast Cancer

AU - Sun, Kai

AU - Xu, Yitian

AU - Mathur, Sunil

AU - Bernicker, Eric H.

AU - Chang, Jenny C.

PY - 2022/10/15

Y1 - 2022/10/15

U2 - 10.1158/1078-0432.CCR-22-0622

DO - 10.1158/1078-0432.CCR-22-0622

M3 - Article

SN - 1078-0432

JO - Clinical Cancer Research

JF - Clinical Cancer Research

ER -